Skip to content
Tagged articles

macrocyclic peptide

1 articles · Page 1 of 1
Machine Heart
Machine Heart
Oct 26, 2026 · Artificial Intelligence

MMDesign Achieves 94.7% Success Rate Across 19 Targets with Only Dozens of Experimental Tests

Molecule Heart's MMDesign platform demonstrates a reproducible AI de novo design workflow achieving 94.7% project success rate across 19 targets including six GPCRs, with only 9-50 candidates tested per project, and shows iterative improvement and macrocyclic peptide extension backed by the high-performing MMFold structure prediction model.

AI de novo designGPCRMMDesign
0 likes · 11 min read
MMDesign Achieves 94.7% Success Rate Across 19 Targets with Only Dozens of Experimental Tests